CN Patent

CN110291079A — 与吡啶酰基哌啶5-ht1f激动剂相关的组合物和方法

Assigned to Colucid Pharmaceuticals Inc · Expires 2019-09-27 · 7y expired

What this patent protects

本发明提供可用在例如用于治疗和预防偏头痛的药物组合物中的2,4,6‑三氟‑N‑[6‑(1‑甲基‑哌啶‑4‑羰基)‑吡啶‑2‑基]‑苯甲酰胺的半琥珀酸盐的新型假多晶型。

USPTO Abstract

本发明提供可用在例如用于治疗和预防偏头痛的药物组合物中的2,4,6‑三氟‑N‑[6‑(1‑甲基‑哌啶‑4‑羰基)‑吡啶‑2‑基]‑苯甲酰胺的半琥珀酸盐的新型假多晶型。

Drugs covered by this patent

Patent Metadata

Patent number
CN110291079A
Jurisdiction
CN
Classification
—
Expires
2019-09-27
Drug substance claim
No
Drug product claim
No
Assignee
Colucid Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.